Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 17.50
+1.55 (9.72%)
Oct 20, 2026, 1:19 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 865.64 million as of October 20, 2026. It is the 35,072nd most valuable company in the world and the 2,117th biggest in Taiwan. Its market cap has decreased by 11.62% in one year.
Market Cap
865.64M
Enterprise Value
692.56M
Revenue
195.89M
Global Rank
Country Rank
#2,117 Taiwan
PE Ratio
177.68
ChartMarket Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 865.64M, an increase of 236.33%. That is a compound annual growth rate of 5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 865.64M | -32.69% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.21B |
| InnoPharmax | 1.13B |
| Excelsior Biopharma | 1.11B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 874.13M |
| Winston Medical Supply | 801.14M |
| Original BioMedicals | 795.02M |